Addressing wastage and distribution challenges for a more equitable post-pandemic pharmaceutical industry
When functioning properly, globalised supply chains broaden access to critical medicines for billions of individuals all over the world. Yet, any number of issues, from macro events such as the recent COVID-19 pandemic or the 2010 volcanic eruption in Iceland, through to more simple patient misunderstandings, can lead to expensive and often unnecessary wastage
